Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Plasmodium falciparum heme detoxification system is a critical metabolic pathway located within the parasite's acidic food vacuole (Coronado et al., 2014, Toxins). During the intraerythrocytic stage of its life cycle, the parasite ingests and degrades host hemoglobin to obtain essential amino acids, a process that releases large quantities of toxic ferriprotoporphyrin IX, also known as free heme (Sullivan, 2002, Int J Parasitol). To prevent the lethal oxidative damage and membrane disruption caused by free heme, the parasite utilizes specialized proteins, including the Heme Detoxification Protein (HDP) and Histidine-Rich Proteins (HRPs), to catalyze the sequestration and crystallization of heme into an insoluble, chemically inert pigment called hemozoin (Jani et al., 2008, PLoS Pathogens). This detoxification mechanism is the primary therapeutic target for several major classes of antimalarial drugs, most notably the quinolines (e.g., chloroquine, quinine) and artemisinins (WHO, 2023, Malaria Guidelines). These drugs act by either inhibiting the biocrystallization process or reacting with heme to form toxic adducts, ultimately leading to parasite death through oxidative stress and cellular lysis (NCBI, 2022, Malaria Parasite Heme Detoxification). The system is also central to the study of antimalarial resistance, as mutations in transporters like PfCRT can reduce drug accumulation at the site of heme detoxification (UniProt, 2024, Q8I2V9).
Inhibition of heme biocrystallization into hemozoin and formation of toxic drug-heme complexes leading to oxidative stress and membrane damage.
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Plasmodium falciparum heme detoxification system (PfHDS) (PfHDS).